Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.1812 -0.0051 (-2.74%)
Streaming Delayed Price Updated: 9:37 AM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Submits Protocol for Phase II Concussion Trial in New Zealand
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Intranasal Drug Delivery at Boston Summit
Via Investor Brand Network
Wondering what's happening in today's after-hours session?
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
InvestorNewsBreaks – Oragenics Inc. Highlights Q1 Milestones and Prepares for Concussion Drug Trial
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. Files 2024 Annual Report, Addresses Going Concern Status
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. Advances Concussion Treatment with Phase II Trial Preparation
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Highlights Concussion Treatment Advances at Emergencies in Medicine Conference
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Appoints Chief Medical Officer to Medical Board of The Leigh Steinberg Foundation
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Partners With BRAINBox Solutions to Advance Concussion Care
Via Investor Brand Network
Most active stocks in Wednesday's session
Let's dive into the action on the US markets on Wednesday. Here are the most active stocks that are driving the market today. 
Via Chartmill
What's going on in today's session
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
The market is filled with gapping stocks in Wednesday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
US Stocks Mixed; Walt Disney Posts Upbeat Earnings
Via Benzinga
These stocks are moving in today's pre-market session
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Chief Medical Officer to Speak at Brain Health Summit During Super Bowl Week
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What's going on in today's after hours session
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Advances ONP-002 Development, Appoints Janet Huffman as Interim CEO
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Streamlines Capital Structure with Preferred Stock Conversion
Via Investor Brand Network
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Oragenics to Present at Centurion One Capital 2nd Annual Bahamas Summit
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
BioMedNewsBreaks — Oragenics, Inc. (NYSE American: OGEN) Reports on Lead Candidate Drug Development, ‘Urgency’ to Advance First-in-Class Concussion Treatment
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Advances Concussion Treatment with Promising Study for Nasal Spray Drug ONP-002
Via Investor Brand Network
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate
Oragenics completed a key study showing its nasal spray drug ONP-002 effectively targets brain-related nasal areas, setting the stage for Phase 2 trials in concussion treatment. 
Via Benzinga
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS